• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃切除术后近端和远端胃癌总生存的比较:系统评价和荟萃分析。

Comparison of the overall survival of proximal and distal gastric cancer after gastrectomy: a systematic review and meta-analysis.

机构信息

Department of Gastroenterology Surgery, The Dalian Municipal Central Hospital Affiliated of Dalian Medical University, No. 826 Southwest Road Shahekou District, Dalian, 116033, P.R. China.

Dalian Medical University, Dalian, 116011, P.R. China.

出版信息

World J Surg Oncol. 2021 Jan 19;19(1):17. doi: 10.1186/s12957-021-02126-4.

DOI:10.1186/s12957-021-02126-4
PMID:33468158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7816301/
Abstract

BACKGROUND

The aim of this study was to investigate the overall survival (OS) between proximal gastric cancer (PG) and distal gastric cancer (DG) patients after gastrectomy.

METHODS

Articles on the prognostic study of PG and DG patients after gastrectomy were collected from the PubMed, EMBASE, Web of Science, Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang, and VIP databases from the date of establishment until December 2020. The data were statistically analyzed by Stata software (version 11.0, StataCorp).

RESULTS

A total of 10 articles met the inclusion criteria. Meta-analysis showed that the 1-, 3- and 5-year OS rates of PG patients were significantly lower than those of DG patients (RR = 0.898, 95% CI: 0.825 to 0.977, P = 0.013; RR = 0.802, 95% CI: 0.708 to 0.909, P = 0.001; RR = 0.736, 95% CI: 0.642 to 0.844, P = 0.000). After subgroup analysis according to different countries, the combined RR values of were as follows: 1-year OS: eastern countries: RR = 0.966, 95% CI: 0.944 to 0.988, P = 0.003, western countries: RR = 0.687, 95% CI: 0.622 to 0.759, P = 0.000; 3-year OS: eastern countries: RR = 0.846, 95% CI: 0.771 to 0.929, P = 0.000, western countries: RR = 0.742, 95% CI: 0.399 to 1.382, P = 0.348; and 5-year OS: eastern countries: RR = 0.798, 95% CI: 0.716 to 0.889, P = 0.000, western countries: RR = 0.646, 95% CI: 0.414 to 1.008, P = 0.054.

CONCLUSION

In terms of 1-, 3-, and 5-year OS, PG patients had lower rates than DG patients and the eastern countries/western countries subgroup, but there were no significant differences in 3- and 5-year OS for the western countries. These results merit further clinical validation in future studies. (Registration ID: UMIN000040393; Date of registration: 2020/05/13).

摘要

背景

本研究旨在探讨胃切除术后近端胃癌(PG)和远端胃癌(DG)患者的总生存率(OS)。

方法

从 PubMed、EMBASE、Web of Science、Cochrane 图书馆、中国知网(CNKI)、万方和 VIP 数据库中收集了关于 PG 和 DG 患者胃切除术后预后研究的文章,检索时间为建库至 2020 年 12 月。使用 Stata 软件(版本 11.0,StataCorp)对数据进行统计分析。

结果

共纳入 10 篇符合条件的文章。Meta 分析显示,PG 患者的 1、3 和 5 年 OS 率明显低于 DG 患者(RR=0.898,95%CI:0.825 至 0.977,P=0.013;RR=0.802,95%CI:0.708 至 0.909,P=0.001;RR=0.736,95%CI:0.642 至 0.844,P=0.000)。根据不同国家进行亚组分析后,合并 RR 值如下:1 年 OS:东部国家:RR=0.966,95%CI:0.944 至 0.988,P=0.003,西方国家:RR=0.687,95%CI:0.622 至 0.759,P=0.000;3 年 OS:东部国家:RR=0.846,95%CI:0.771 至 0.929,P=0.000,西方国家:RR=0.742,95%CI:0.399 至 1.382,P=0.348;5 年 OS:东部国家:RR=0.798,95%CI:0.716 至 0.889,P=0.000,西方国家:RR=0.646,95%CI:0.414 至 1.008,P=0.054。

结论

在 1、3 和 5 年 OS 方面,PG 患者的生存率低于 DG 患者和东部/西部国家亚组,但西方国家的 3 年和 5 年 OS 无显著差异。这些结果值得在未来的研究中进一步临床验证。(注册号:UMIN000040393;注册日期:2020/05/13)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d2a/7816301/c2be67af5b7a/12957_2021_2126_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d2a/7816301/093595752974/12957_2021_2126_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d2a/7816301/d574755a44c6/12957_2021_2126_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d2a/7816301/e26a7ac512c7/12957_2021_2126_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d2a/7816301/b6988566734e/12957_2021_2126_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d2a/7816301/c2be67af5b7a/12957_2021_2126_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d2a/7816301/093595752974/12957_2021_2126_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d2a/7816301/d574755a44c6/12957_2021_2126_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d2a/7816301/e26a7ac512c7/12957_2021_2126_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d2a/7816301/b6988566734e/12957_2021_2126_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d2a/7816301/c2be67af5b7a/12957_2021_2126_Fig5_HTML.jpg

相似文献

1
Comparison of the overall survival of proximal and distal gastric cancer after gastrectomy: a systematic review and meta-analysis.胃切除术后近端和远端胃癌总生存的比较:系统评价和荟萃分析。
World J Surg Oncol. 2021 Jan 19;19(1):17. doi: 10.1186/s12957-021-02126-4.
2
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
3
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
4
Treatment options for progression or recurrence of glioblastoma: a network meta-analysis.治疗胶质母细胞瘤进展或复发的选择:网络荟萃分析。
Cochrane Database Syst Rev. 2021 May 4;5(1):CD013579. doi: 10.1002/14651858.CD013579.pub2.
5
Short-and long-term outcomes of laparoscopic versus open gastrectomy in patients with gastric cancer: a systematic review and meta-analysis of randomized controlled trials.腹腔镜与开腹胃癌根治术治疗胃癌的近期和远期疗效:系统评价和随机对照试验的荟萃分析。
World J Surg Oncol. 2022 Dec 24;20(1):405. doi: 10.1186/s12957-022-02818-5.
6
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD010216. doi: 10.1002/14651858.CD010216.pub7.
7
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2021 Sep 14;9(9):CD010216. doi: 10.1002/14651858.CD010216.pub6.
8
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
9
Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines.右雷佐生预防或减少接受蒽环类抗生素治疗的癌症成人和儿童的心脏毒性。
Cochrane Database Syst Rev. 2022 Sep 27;9(9):CD014638. doi: 10.1002/14651858.CD014638.pub2.
10
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.

引用本文的文献

1
Gastric Cancer Surgery Before and During the COVID-19 Pandemic in Turkey: A Multicenter Comparison of Prognostic Factors, Mortality, and Survival.土耳其 COVID-19 大流行之前及期间的胃癌手术:预后因素、死亡率和生存率的多中心比较
Medicina (Kaunas). 2025 Jul 24;61(8):1336. doi: 10.3390/medicina61081336.
2
Impact of Treatment Modalities on Locally Advanced Gastric Cancer-Real-World Data.治疗方式对局部晚期胃癌的影响——真实世界数据
Curr Oncol. 2025 Aug 16;32(8):463. doi: 10.3390/curroncol32080463.
3
Different Master Regulators Define Proximal and Distal Gastric Cancer: Insights into Prognosis and Opportunities for Targeted Therapy.

本文引用的文献

1
Comparison on Clinicopathological Features, Treatments and Prognosis between Proximal Gastric Cancer and Distal Gastric Cancer: A National Cancer Data Base Analysis.近端胃癌与远端胃癌的临床病理特征、治疗及预后比较:一项国家癌症数据库分析
J Cancer. 2019 Jun 2;10(14):3145-3153. doi: 10.7150/jca.30371. eCollection 2019.
2
[Surgical treatment strategy for advanced gastric cancer].[进展期胃癌的外科治疗策略]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Oct 25;21(10):1099-1102.
3
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
不同的主调控因子界定近端和远端胃癌:对预后的见解及靶向治疗机会
Curr Oncol. 2025 Jul 28;32(8):424. doi: 10.3390/curroncol32080424.
4
Real-world outcomes of Adjuvant De Gramont versus Xelox chemotherapy in reSected gasTric cancER: a propensity score-matched analysis (ASTER study).辅助性德格拉蒙化疗与希罗达化疗用于胃癌切除术后的真实世界疗效:一项倾向评分匹配分析(ASTER研究)
Cancer Gene Ther. 2025 Jul 26. doi: 10.1038/s41417-025-00945-1.
5
Effect of double-tract reconstruction and laparoscopic proximal gastrectomy on immune function and stress.双通道重建与腹腔镜近端胃切除术对免疫功能和应激的影响
World J Gastrointest Surg. 2025 Jun 27;17(6):104192. doi: 10.4240/wjgs.v17.i6.104192.
6
Asia Pacific Gastroesophageal Cancer Congress (APGCC) 2024 consensus statement on stage 2 and 3 locally advanced gastric and Siewert 3 junctional adenocarcinoma.2024年亚太地区食管癌大会(APGCC)关于2期和3期局部晚期胃癌及Siewert 3型交界腺癌的共识声明
J Gastroenterol. 2025 Jun 13. doi: 10.1007/s00535-025-02266-4.
7
Downregulation of huntingtin-associated protein 1 predicts poor prognosis in gastric cancer.亨廷顿蛋白相关蛋白1的下调预示着胃癌的预后不良。
World J Clin Oncol. 2025 Apr 24;16(4):102958. doi: 10.5306/wjco.v16.i4.102958.
8
A predictive model and rapid multi-dynamic algorithm developed based on tumor-stroma percentage in gastric cancer: a retrospective, observational study.基于胃癌肿瘤-基质百分比建立的预测模型及快速多动态算法:一项回顾性观察研究。
Gastroenterol Rep (Oxf). 2024 Oct 11;12:goae083. doi: 10.1093/gastro/goae083. eCollection 2024.
9
Constructing a Clinical Patient Similarity Network of Gastric Cancer.构建胃癌临床患者相似性网络。
Bioengineering (Basel). 2024 Aug 9;11(8):808. doi: 10.3390/bioengineering11080808.
10
Evaluation of Immunohistochemical Expression of Survivin and its Correlation with qRT-PCR Results as a Useful Diagnostic Marker in Gastric Cancer.生存素免疫组化表达的评估及其与qRT-PCR结果的相关性作为胃癌有用诊断标志物的研究
Iran J Public Health. 2024 Feb;53(2):462-471. doi: 10.18502/ijph.v53i2.14931.
全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
4
Progress in gastric cancer.胃癌的进展
Updates Surg. 2018 Jun;70(2):157-159. doi: 10.1007/s13304-018-0543-3. Epub 2018 Jun 5.
5
Clinicopathologic characteristics and prognosis of proximal and distal gastric cancer.近端和远端胃癌的临床病理特征及预后
Onco Targets Ther. 2018 Feb 27;11:1037-1044. doi: 10.2147/OTT.S157378. eCollection 2018.
6
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.AMSTAR 2:一种用于系统评价的关键评估工具,该系统评价包括医疗保健干预措施的随机或非随机研究,或两者皆有。
BMJ. 2017 Sep 21;358:j4008. doi: 10.1136/bmj.j4008.
7
Progress in the treatment of advanced gastric cancer.晚期胃癌治疗的进展
Tumour Biol. 2017 Jul;39(7):1010428317714626. doi: 10.1177/1010428317714626.
8
DO PROXIMAL AND DISTAL GASTRIC TUMOURS BEHAVE DIFFERENTLY?近端和远端胃癌的行为是否不同?
Arq Bras Cir Dig. 2016 Nov-Dec;29(4):232-235. doi: 10.1590/0102-6720201600040005.
9
Clinical Relevance of the Tumor Location-Modified Lauren Classification System of Gastric Cancer.肿瘤位置改良的胃癌劳伦分类系统的临床相关性
J Gastric Cancer. 2015 Sep;15(3):183-90. doi: 10.5230/jgc.2015.15.3.183. Epub 2015 Sep 30.
10
Clinicopathological characterisation of small (2 cm or less) proximal and distal gastric carcinomas in a Chinese population.中国人群中小(2厘米及以下)近端和远端胃癌的临床病理特征
Pathology. 2015 Oct;47(6):526-32. doi: 10.1097/PAT.0000000000000276.